Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Goodwill & Intangibles (2016 - 2025)

Amicus Therapeutics' Goodwill & Intangibles history spans 13 years, with the latest figure at $211.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Goodwill & Intangibles fell 1.53% year-over-year to $211.7 million, compared with a TTM value of $211.7 million through Dec 2025, down 1.53%, and an annual FY2025 reading of $211.7 million, down 1.53% over the prior year.
  • Goodwill & Intangibles for Q4 2025 was $211.7 million at Amicus Therapeutics, roughly flat from $212.5 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $220.8 million in Q1 2021, with the low at $211.7 million in Q4 2025.
  • Average Goodwill & Intangibles over 5 years is $218.1 million, with a median of $219.5 million recorded in 2023.
  • Year-over-year, Goodwill & Intangibles changed 0.0% in 2021 and then dropped 1.53% in 2025.
  • Tracing FOLD's Goodwill & Intangibles over 5 years: stood at $220.8 million in 2021, then changed by 0.0% to $220.8 million in 2022, then decreased by 1.14% to $218.3 million in 2023, then decreased by 1.51% to $215.0 million in 2024, then decreased by 1.53% to $211.7 million in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Goodwill & Intangibles are $211.7 million (Q4 2025), $212.5 million (Q3 2025), and $213.4 million (Q2 2025).